08/27/2026
Key advances in off-target assays make cell-based, population-scale analysis possible.
Check out our latest case study to learn how our Tagify i5 UMI and GUIDE-seq2 enabled the first genome-wide, large-scale study of the effects of genetic variation on Cas9 off-target activity to improve gene therapy efficacy and safety.
https://hubs.ly/Q04vxWlK0